Work with thought leaders and academic experts in nephrology
Companies can greatly benefit from working with experts in the field of nephrology. These researchers bring a deep understanding of kidney diseases, treatments, and advancements. By collaborating with nephrology thought leaders, companies can enhance their research and development efforts, gain valuable insights into the latest trends and technologies, and accelerate innovation in the field. Whether it's developing new drugs, medical devices, or treatment protocols, partnering with nephrology experts can lead to breakthrough discoveries and improved patient outcomes.
Researchers on NotedSource with backgrounds in nephrology include Luke Connelly, Sheila Monfared, Ph.D., Kalpita R. Karan, Leo R Fitzpatrick PhD, Moji Ghadimi, Professor Esper A. Cavalheiro, Charles T. Hill, PhD, Xander van Wijk, PhD, DABCC, FADLM, Mohamad Hadla, Yasmeen George, Anil Kumar, Mehrdad Sheikhvatan, and Dr. Craig Pfeifer PhD, ATC, FHEA.
Luke Connelly
Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Expertise
Other Research Expertise (42)
About
Most Relevant Publications (1+)
105 total publications
Geriatric CKD: Value-Based Nephrology
Advances in Chronic Kidney Disease / Jan 01, 2016
Yee, J. (2016). Geriatric CKD: Value-Based Nephrology. Advances in Chronic Kidney Disease, 23(1), 1–5. https://doi.org/10.1053/j.ackd.2015.11.001
See Full Profile
Sheila Monfared, Ph.D.
Specialist in Psychology, Human Factors, and Social Engineering: Delivering Impactful Research Solutions in academia and Industry
Most Relevant Research Expertise
Other Research Expertise (12)
About
Most Relevant Publications (1+)
6 total publications
A Bio-Physio-Psychological Investigation of Athletes’ Burnout
Research Quarterly for Exercise and Sport / Feb 28, 2020
Monfared, S. S., Lebeau, J.-C., Mason, J., Cho, S. K., Basevitch, I., Perry, I., Baur, D. A., & Tenenbaum, G. (2020). A Bio-Physio-Psychological Investigation of Athletes’ Burnout. Research Quarterly for Exercise and Sport, 92(1), 189–198. https://doi.org/10.1080/02701367.2020.1715911
See Full Profile
Kalpita R. Karan
Ph.D. with a over 8 years of experience in human genetics and molecular biology. Presently, pushing pre-clinical discovery pipelines in human gene therapy at Weill Cornell Medicine.
Most Relevant Research Expertise
Other Research Expertise (24)
About
Most Relevant Publications (1+)
23 total publications
Mitochondrial respiratory capacity modulates LPS-induced inflammatory signatures in human blood
Brain, Behavior, & Immunity - Health / May 01, 2020
Karan, K. R., Trumpff, C., McGill, M. A., Thomas, J. E., Sturm, G., Lauriola, V., Sloan, R. P., Rohleder, N., Kaufman, B. A., Marsland, A. L., & Picard, M. (2020). Mitochondrial respiratory capacity modulates LPS-induced inflammatory signatures in human blood. Brain, Behavior, & Immunity - Health, 5, 100080. https://doi.org/10.1016/j.bbih.2020.100080
See Full Profile
Leo R Fitzpatrick PhD
GI Pharmacology and IBD Research Consultant
Most Relevant Research Expertise
Other Research Expertise (32)
About
Most Relevant Publications (1+)
89 total publications
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice
International Journal of Nephrology and Renovascular Disease / Nov 01, 2022
Maines, L. W., Green, C. L., Keller, S. N., Fitzpatrick, L. R., & Smith, C. D. (2022). The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice. International Journal of Nephrology and Renovascular Disease, Volume 15, 323–334. https://doi.org/10.2147/ijnrd.s386396
See Full Profile
Moji Ghadimi
Senior Research Fellow, University of Queensland
Most Relevant Research Expertise
Other Research Expertise (16)
About
Most Relevant Publications (1+)
19 total publications
POS-849 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY
Kidney International Reports / Feb 01, 2022
ESCUDERO, A. E., Ferrer, F., & Pascual, C. (2022). POS-849 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY. Kidney International Reports, 7(2), S366–S367. https://doi.org/10.1016/j.ekir.2022.01.887
See Full Profile
Professor Esper A. Cavalheiro
Professor Emeritus at Departamento de Neurologia e Neurocirurgia, Escola Paulista de Medicina/UNIFESP
Most Relevant Research Expertise
Other Research Expertise (58)
About
Most Relevant Publications (2+)
406 total publications
Sudden unexpected death in patients with epilepsy receiving renal replacement therapy with dialysis: A 17‐year experience at a single institution
Hemodialysis International / Oct 01, 2010
SCORZA, F. A., SCATTOLINI, M., CYSNEIROS, R. M., ARIDA, R. M., DE ALBUQUERQUE, M., TERRA, V. C., MACHADO, H. R., GOMES, R. A., KESROUANI, S., CRUZ, J., PELARIGO, F. C. M., SILVA, A. L., HENRIQUES, T. M. G., & CAVALHEIRO, E. A. (2010). Sudden unexpected death in patients with epilepsy receiving renal replacement therapy with dialysis: A 17‐year experience at a single institution. Hemodialysis International, 14(4), 364–369. Portico. https://doi.org/10.1111/j.1542-4758.2010.00492.x
Cardiovascular abnormalities in patients with epilepsy receiving renal replacement therapy with dialysis: a true convergence of clinical cardiology, nephrology and neurology
Nephrology Dialysis Transplantation / Feb 26, 2008
Scorza, F. A., Arida, R. M., & Cavalheiro, E. A. (2008). Cardiovascular abnormalities in patients with epilepsy receiving renal replacement therapy with dialysis: a true convergence of clinical cardiology, nephrology and neurology. Nephrology Dialysis Transplantation, 23(5), 1775–1776. https://doi.org/10.1093/ndt/gfn017
See Full Profile
Xander van Wijk, PhD, DABCC, FADLM
Strategic Leader in Clinical Diagnostics | Expert in Laboratory and Precision Medicine | Award-Winning Scientist & Author | CLIA Laboratory Director
Most Relevant Research Expertise
Other Research Expertise (40)
About
Most Relevant Publications (2+)
59 total publications
Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis
Kidney International / Nov 01, 2014
LWMM Rops, A., Loeven, M. A., van Gemst, J. J., Eversen, I., Van Wijk, X. M., Dijkman, H. B., van Kuppevelt, T. H., Berden, J. H. M., Rabelink, T. J., Esko, J. D., & van der Vlag, J. (2014). Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis. Kidney International, 86(5), 932–942. https://doi.org/10.1038/ki.2014.115
Large inter-assay difference of serum creatinine in pediatric population: a threat to accurate staging of chronic kidney disease
Pediatric Nephrology / Nov 10, 2021
Lao, K., Sykes, E., van Wijk, X. M. R., Li, J., Williams, J., Gherasim, C., & Sun, Q. (2021). Large inter-assay difference of serum creatinine in pediatric population: a threat to accurate staging of chronic kidney disease. Pediatric Nephrology, 37(3), 677–681. https://doi.org/10.1007/s00467-021-05335-x
See Full Profile
Mohamad Hadla
Senior Research Fellow, Mayo Clinic
Most Relevant Research Expertise
Other Research Expertise (20)
Most Relevant Publications (1+)
17 total publications
MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection
Nephrology Dialysis Transplantation / May 01, 2022
Ciceri, P., Bono, V., Magagnoli, L., Sala, M., Artioli, L., Rovito, R., Hadla, M., Yellenki, V., D’arminio Monforte, A., Galassi, A., Tincati, C., Marchetti, G., & Gennaro Cozzolino, M. (2022). MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection. Nephrology Dialysis Transplantation, 37(Supplement_3). https://doi.org/10.1093/ndt/gfac070.023
See Full Profile
Anil Kumar
University of Georgia (UGA), USA
Most Relevant Research Expertise
Other Research Expertise (58)
Most Relevant Publications (1+)
89 total publications
Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins
Kidney International / Nov 01, 1995
Kanwar, Y. S., Liu, Z. Z., Kumar, A., Wada, J., & Carone, F. A. (1995). Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins. Kidney International, 48(5), 1646–1659. https://doi.org/10.1038/ki.1995.460
See Full Profile
Mehrdad Sheikhvatan
Iran University of Medical Sciences
Most Relevant Research Expertise
Other Research Expertise (48)
Most Relevant Publications (1+)
89 total publications
The value of N-terminal pro-B-type natriuretic peptide (NT Pro-BNP) to predict sudden cardiac death in chronic heart failure patients with normal renal function; a systematic review and meta-analysis
Journal of Nephropharmacology / Jul 27, 2018
Sheikhvatan, M., Ataei, Z., Heydari, A., & Zahergivar, A. (2018). The value of N-terminal pro-B-type natriuretic peptide (NT Pro-BNP) to predict sudden cardiac death in chronic heart failure patients with normal renal function; a systematic review and meta-analysis. Journal of Nephropharmacology, 7(2), 164–168. https://doi.org/10.15171/npj.2018.32
See Full Profile
Dr. Craig Pfeifer PhD, ATC, FHEA
Most Relevant Research Expertise
Other Research Expertise (7)
Most Relevant Publications (1+)
20 total publications
Comparison of Indirect Calorimetry- and Accelerometry-Based Energy Expenditure During Children‘s Discrete Skill Performance
Research Quarterly for Exercise and Sport / Aug 23, 2019
Sacko, R., McIver, K., Brazendale, K., Pfeifer, C., Brian, A., Nesbitt, D., & Stodden, D. F. (2019). Comparison of Indirect Calorimetry- and Accelerometry-Based Energy Expenditure During Children‘s Discrete Skill Performance. Research Quarterly for Exercise and Sport, 90(4), 629–640. https://doi.org/10.1080/02701367.2019.1642440
See Full Profile
Example nephrology projects
How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on nephrology?
Drug Development for Kidney Diseases
A pharmaceutical company can collaborate with a nephrology researcher to develop new drugs for kidney diseases. The researcher's expertise in understanding the underlying mechanisms of kidney diseases and their experience in conducting clinical trials can greatly contribute to the development of effective and safe medications.
Medical Device Innovation
A medical device company can partner with a nephrology expert to innovate and improve devices used in dialysis treatments. The researcher's knowledge of dialysis procedures and patient needs can help in designing more efficient and user-friendly devices, leading to better treatment outcomes and enhanced patient experience.
Precision Medicine in Nephrology
A biotech company can collaborate with a nephrology researcher to develop personalized treatment approaches for kidney diseases. By analyzing genetic and molecular data, the researcher can identify biomarkers and genetic variants that influence disease progression and response to treatment, enabling the development of targeted therapies for individual patients.
Telemedicine Solutions for Nephrology
A healthcare technology company can work with a nephrology expert to develop telemedicine solutions for remote monitoring and management of kidney diseases. The researcher's understanding of the unique challenges faced by nephrology patients and their expertise in leveraging technology can help in creating user-friendly platforms that improve access to care and enable timely interventions.
Clinical Trials and Research Collaborations
Companies involved in clinical research can collaborate with nephrology researchers to conduct clinical trials and studies related to kidney diseases. The researcher's knowledge of disease mechanisms, patient populations, and research methodologies can contribute to the successful execution of trials, leading to the development of evidence-based treatments and therapies.